For: | Tsuzuki T, Okada H, Kawahara Y, Takenaka R, Nasu J, Ishioka H, Fujiwara A, Yoshinaga F, Yamamoto K. Proton pump inhibitor step-down therapy for GERD: A multi-center study in Japan. World J Gastroenterol 2011; 17(11): 1480-1487 [PMID: 21472108 DOI: 10.3748/wjg.v17.i11.1480] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v17/i11/1480.htm |
Number | Citing Articles |
1 |
Mohammad Osmani, Freshteh Osmani, Mohammad Amin Pourhoseingholi. Comparison of Decision Tree and Logistic Regression for Prediction of Functional Dyspepsia and Gastroesophageal Reflux Disease in Tehran Province Using Rome III. Modern Care Journal 2019; 16(4) doi: 10.5812/modernc.94669
|
2 |
Yixuan Du, Ashley Spencer, Pabitra Roy, Ahmed Abdulhamid, Shannon Dalessio, John Levenick, Jennifer Maranki, Hadie Razjouyan, Matthew D. Coates. Asymptomatic Erosive Esophagitis. Digestive Diseases and Sciences 2025; 70(2): 462 doi: 10.1007/s10620-024-08793-z
|
3 |
Deepthi Pulivarthi, Ravinder Reddy Patlolla, Joshna Kuni, Raveena Gajjala, Santhosh Nayak Kethavath, Linga Banoth, Subba Reddy B V. Enzymatic kinetic resolution of an intermediate alcohol of the drug Tegoprazan using lipase from Thermomyces lanuginosus. Biocatalysis and Biotransformation 2024; 42(6): 653 doi: 10.1080/10242422.2024.2326421
|
4 |
Amir Mari, Elisa Marabotto, Mentore Ribolsi, Fabiana Zingone, Brigida Barberio, Vincenzo Savarino, Edoardo Vincenzo Savarino. Encouraging appropriate use of proton pump inhibitors: existing initiatives and proposals for the future. Expert Review of Clinical Pharmacology 2023; 16(10): 913 doi: 10.1080/17512433.2023.2252327
|
5 |
Jeremy Klein, Robert T. Kavitt. Gastroesophageal Reflux Disease. 2023; : 61 doi: 10.1007/978-3-031-48241-0_8
|
6 |
Mychailo Pliatsko. GASTROESOPHAGEAL REFLUX DISEASE – IS THE MODERN TREATMENT STANDARTS SUFFICIENT TO SOLVE THE PROBLEM?. Proceedings of the Shevchenko Scientific Society Medical sciences 2017; 49(1): 78 doi: 10.25040/ntsh2017.01.06
|
7 |
Naomi Gronich, Idit lavi, Flavio Lejbkowicz, Mila Pinchev, Gad Rennert. Association of CYP2C19 Polymorphism With Proton Pump Inhibitors Effectiveness and With Fractures in Real‐Life: Retrospective Cohort Study. Clinical Pharmacology & Therapeutics 2022; 111(5): 1084 doi: 10.1002/cpt.2552
|
8 |
Hólmfridur Helgadóttir, David C. Metz, Sigrún H. Lund, Sveinbjorn Gizurarson, Elin I. Jacobsen, Gudrún A. Asgeirsdóttir, Yrsa Yngadóttir, Einar S. Björnsson. Study of Gender Differences in Proton Pump Inhibitor Dose Requirements for GERD. Journal of Clinical Gastroenterology 2017; 51(6): 486 doi: 10.1097/MCG.0000000000000542
|
9 |
Marjan Mokhtare, Arezoo Chaharmahali, Mansour Bahardoust, Atefeh Ghanbari, Arash Sarveazad, Roozbeh Naghshin, Farbod Abbaskhanidavanloo. The effect of adding duloxetine to lansoprazole on symptom and quality of life improvement in patients with gastroesophageal reflux diseases. Journal of Research in Medical Sciences 2021; 26(1): 4 doi: 10.4103/jrms.JRMS_300_19
|
10 |
Marcela Forgerini, Stephania Mieli, Patrícia de Carvalho Mastroianni. Safety assessment of omeprazole use: a review. Sao Paulo Medical Journal 2018; 136(6): 557 doi: 10.1590/1516-3180.2018.0019220318
|
11 |
Yoshikazu Kinoshita, Hiroto Miwa, Katsuyuki Sanada, Koji Miyata, Ken Haruma. Clinical characteristics and effectiveness of lansoprazole in Japanese patients with gastroesophageal reflux disease and dyspepsia. Journal of Gastroenterology 2014; 49(4): 628 doi: 10.1007/s00535-013-0812-3
|
12 |
Charles Muller, Natalie Tapaskar, Robert T. Kavitt. Foregut Surgery. 2020; : 121 doi: 10.1007/978-3-030-27592-1_14
|
13 |
Daniel A. Kroch, Ryan D. Madanick. Medical Treatment of Gastroesophageal Reflux Disease. World Journal of Surgery 2017; 41(7): 1678 doi: 10.1007/s00268-017-3954-2
|
14 |
Eric Alan Gaumnitz. Gastroesophageal Reflux and the Lung. 2012; : 227 doi: 10.1007/978-1-4614-5502-8_12
|
15 |
Holmfridur Helgadottir, Einar S. Bjornsson. Problems Associated with Deprescribing of Proton Pump Inhibitors. International Journal of Molecular Sciences 2019; 20(21): 5469 doi: 10.3390/ijms20215469
|
16 |
Akihito Nagahara, Mariko Hojo, Daisuke Asaoka, Hitoshi Sasaki, Sumio Watanabe. A randomized prospective study comparing the efficacy of on-demand therapy versus continuous therapy for 6 months for long-term maintenance with omeprazole 20 mg in patients with gastroesophageal reflux disease in Japan. Scandinavian Journal of Gastroenterology 2014; 49(4): 409 doi: 10.3109/00365521.2013.878380
|